Spotlight Archive - Wing Tech Inc.

About

Expertise

Methodology

Insights

Publications

Contact

Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000

Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000

Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900

consulting@wing-tech.com

About

Expertise

Methodology

Insights

Publications

Contact

Wing Tech Inc.
9916 Newhall Rd.
Potomac, MD 20854
+1 301 660 8000

Wing Tech Inc.
101 Jefferson Dr.
Menlo Park, CA 94025
+1 650 943 3000

Wingtec GmbH
Im Rosengärtle 14
Karlsruhe, DE
+49 721 56044 900

consulting@wing-tech.com

We found 17 results

- Meta-analysis of endovascular treatment of long lesions presented at SCAI 2025
- Study lead author Dr. Sameh Sayfo (Baylor Scott & White Legacy Heart Center, Plano, TX) presented on the findings of a Wing Tech-led systematic search and meta-analysis of outcomes of endovascular treatment of long lesions in femoropopliteal artery disease at the SCAI 2025 Scientific Session in Washington, DC.

- Podium presentation at EuroPCR in Paris/France
- Andrew Sharp (University College Dublin, Ireland) will present “Cost-effectiveness of radiofrequency renal denervation in five European countries” at a session at EuroPCR 2025, the world-leading course in interventional cardiovascular medicine. The presentation relies on Wing Tech-developed and co-authored health-economic analyses for these five countries.

- Cost-Effectiveness Analysis of Renal Denervation for Hypertension in Sweden published in Blood Pressure
- A country-specific cost-effectiveness analysis of radiofrequency renal denervation for Sweden has been published in Blood Pressure. The study, co-authored by Professors Thomas Kahan and Peter Lindgren (Karolinska Institute, Stockholm) and Wing Tech researchers provides the first analysis of the health-economic value of renal denervation in the Swedish setting.

- Society of Interventional Radiology (SIR) ‘Abstracts of the Year’ presentation at SIR 2025 Annual Scientific Meeting, Nashville, TN
- Study co-author Dr. Nicholas J. Petruzzi, MD, FSIR presented “One-Year Clinical and Lifetime Cost-Effectiveness Outcomes of Transcatheter Arterialization for No-Option CLTI in the U.S.” at the SIR 2025 Annual Meeting. The analysis relies on a Wing Tech-developed cost-effectiveness framework and was selected as one of the SIR ‘Abstracts of the Year’.

- Renal Denervation Study Presentation at EuroPCR
- May 19, 2022, Paris, France: “Projected Clinical Events Avoided in Patients Treated with Renal Denervation” to be presented by Prof. Roland Schmieder based on Wing Tech-developed analysis model. EuroPCR. http://pcronline.com/

- CVIR Publication on Drug-Coated Balloons
- Jan. 4, 2022: Study “Cost-Effectiveness of Urea Excipient-Based Drug-Coated Balloons for Chronic Limb-Threatening Ischemia from Femoropopliteal Disease in the Netherlands and Germany” published in Cardiovascular and Interventional Radiology.

- ACC.21 Presentation on Clinical Event Reductions in High-Risk Hypertension Patients
- May 16, 2021: American College of Cardiology ACC.21 Presentation of model-based projections of clinical events avoided in high-risk hypertension patients based on data from the Global SYMPLICITY Registry.

- Wing Tech US Health-Economic Corelab Activities Expanded
- July 1, 2022: Wing Tech continues to expand its end-to-end health-economic analysis offerings, adding two additional multi-center studies to the portfolio of clinical studies for which Wing Tech serves as health-economic corelab, collecting health-economic data prospectively along-the-trial in support of comprehensive analyses of the value proposition of studied technologies.

- pDVI Cost-Effectiveness Study Published
- May 28, 2021: Wing Tech analysis “Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients With No-Option Chronic Limb-Threatening Ischemia: An Exploratory Analysis Based on the PROMISE I Study” published in Journal of Critical Limb Ischemia